公司5月30日发布公告,拟再融资4.64亿元,发行价格为60.1元/股,这远超我们当初52元/股的预期,彰显长期价值投资者对公司未来的信心。第二代高效开方机横空出世目前国内开方机产品主要被国外的品牌垄断,包括M&B、HCT和NTC,国内少数企业涉足该领域,包括上海日进、大连连称、无锡开源等。公司目前已经开发出第二代开方机产品,效率较传统开方机提升50%,远超国外产品且价格仅为国 The company announced on May 30 that it planned to refinance an additional fund of 464 million yuan at an issue price of 60.1 yuan per share, far exceeding our expectation of 52 yuan per share and highlighting the confidence of long-term value investors in the future of the company. The Second Generation of High-efficiency Preforming Machine Born to Be Adopted At present, China’s preforming machine products are mainly monopolized by foreign brands, including M & B, HCT and NTC. A few domestic enterprises are involved in this field, including Shanghai Rijin, Dalian Liangyuan and Wuxi Open Source. The company has now developed a second-generation prescribing machine products, the efficiency of the traditional machine to enhance 50%, far more than foreign products and the price is only for the country